Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Ovarian, Fallopian Tube, and Peritoneal Cancer

NCT04701645 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT04701645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04701645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Ovarian, Fallopian Tube, and Peritoneal Cancer
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 1
Overall status
Recruiting
Start date
November 1, 2022
Completion date
June 30, 2027
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

fallopian tube cancer, fallopian tube cancer stage iii, fallopian tube cancer stage iv, ovarian cancer, ovarian cancer stage iii, ovarian cancer stage iv, peritoneal cancer